A prospective survey of febrile events in hematological malignancies

Annals of Hematology

Volumn 91, Issue 5, 2012, Pages 767-774

  Pagano, L ^a   Caira, M ^a   Rossi, G ^b,n   Tumbarello, M ^a   Fanci, R ^c   Garzia, M G ^d   Vianelli, N ^e   Filardi, N ^f   De Fabritiis, P ^g   Beltrame, A ^h   Musso, M ⁱ   Piccin, A ^j   Cuneo, A ^k   Cattaneo, C ^b   Aloisi, T ^l   Riva, M ^m   Salvadori, U ^o   Brugiatelli, M ^p   Sannicolo S ^q   Morselli, M ^r   Bonini, A ^s   Viale, P ^e   Nosari, A ^m   Aversa, F ^l   more..

^a CATHOLIC UNIVERSITY   (Italy)

^b SPEDALI CIVILI   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f SAN CARLO HOSPITAL   (Italy)

^g S EUGENIO HOSPITAL   (Italy)

^h TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

ⁱ LA MADDALENA CANCER CENTER   (Italy)

^j Ospedale Generale di Bolzano   (Italy)

^k Az OspArcispedale S A Univ S   (Italy)

^l UNIVERSITY OF PERUGIA   (Italy)

^m OSPEDALE NIGUARDA CA GRANDA   (Italy)

ⁿ CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^o OSPEDALE CA FONCELLO   (Italy)

^p Ospedale Papardo   (Italy)

^q Umberto i   (Italy)

^r UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^s Divisione di Ematologia   (Italy)

more..

Author keywords

Epidemiology; Febrile events; Hematological malignancies; Registry

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOPATHY; ARTICLE; CHRONIC GRANULOCYTIC LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE REGISTRY; DISEASE SURVEILLANCE; ELECTRONIC MEDICAL RECORD; FEVER; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MYCOSIS; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NEUTROPENIA; NEUTROPHIL COUNT; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PYREXIA IDIOPATHICA; VIRUS INFECTION; BACTERIAL INFECTION; BLOOD DISEASE; MIXED INFECTION; MORTALITY;

BACTERIAL INFECTIONS; COINFECTION; FEVER; HEMATOLOGIC NEOPLASMS; HUMANS; MYCOSES; PROSPECTIVE STUDIES; VIRUS DISEASES;

EID: 84861418842     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1373-2     Document Type: Article

References (26)

1. Faensen D, Claus H, Benzler J et al (2006) SurvNet@RKI-a multistate electronic reporting system for communicable diseases. Eur Surveill 11:100-103
2. Guzman D, Veit D, Knerr V et al (2007) The ESID online database network. Bioinformatics 23:654-655 (Pubitemid 46522608)
3. Angelow A, Schmidt M, Weitmann K et al (2008) Methods and implementation of a central biosample and data management in a three-centre clinical study. Comput Methods Programs Biomed 91:82-90
4. Pagano L, Caira M, Nosari A et al (2010) Hema e-Chart: Italian registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies. J Chemother 22:20-24
5. Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52(4):e56-e93
6. Hughes WT, Armstrong D, Bodey GP et al (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730-751 (Pubitemid 34194843)
7. De Pauw B, Walsh TJ, Donnelly JP et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813-1821
8. Wingard JR, Ribaud P, Schlamm HT, Herbrecht R (2008) Changes in causes of death over time after treatment for invasive aspergillosis. Cancer 112:2309-2312 (Pubitemid 351628643)
9. Pagano L, Caira M, Candoni A et al (2006) The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 91:1068-1075 (Pubitemid 44208634)
10. Pagano L, Caira M, Nosari A et al (2007) Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study-Sorveglianza Epidemiologica Infezioni Fungine nelle Emopatie Maligne. Clin Infect Dis 45:1161-1170 (Pubitemid 47580314)
11. Neofytos D, Horn D, Anaissie E et al (2009) Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 48:265-273
12. Hakim H, Flynn PM, Knapp KM, Srivastava DK, Gaur AH (2009) Etiology and clinical course of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol 31:623-629
13. Gupta A, Singh M, Singh H et al (2010) Infections in acute myeloid leukemia: an analysis of 382 febrile episodes. Med Oncol 27:1037-1045
14. Dettenkofer M, Wenzler-Röttele S, Babikir R et al (2005) Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project. Clin Infect Dis 40(7):926-931 (Pubitemid 40418296)
15. Meyer E, Beyersmann J, Bertz H et al (2007) Risk factor analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantation. Bone Marrow Transplant 39(3):173-178 (Pubitemid 46178752)
16. [No authors listed]. EORTC International Antimicrobial Therapy Cooperative Group. Gram-positive bacteraemia in granulocytopenic cancer patients. European Journal of Cancer 1990; 26:569-74
17. Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M (1997) A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol 99:580-588
18. Bucaneve G, Micozzi A, Menichetti F et al (2005) Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 353:977-987 (Pubitemid 41262332)
19. Nørgaard M, Larsson H, Pedersen G, Schønheyder HC, Sørensen HT (2006) Risk of bacteraemia and mortality in patients with haematological malignancies. Clin Microbiol Infect 12(3):217-223 (Pubitemid 43379321)
20. Tumbarello M, Spanu T, CairaMet al (2009) Factors associated with mortality in bacteremic patients with hematologic malignancies. Diagn Microbiol Infect Dis 64:320-326
21. Trecarichi EM, Tumbarello M, Spanu T et al (2009) Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Infect 58:299-307
22. des Champs-Bro B, Leroy-Cotteau A, Mazingue F et al (2011) Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology. J Clin Pharm Ther 36(2):152-160
23. Lortholary O, Gangneux JP, Sitbon K et al (2011) Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007). Clin Microbiol Infect. doi:10.1111/j.1469-0691.2011.03548
24. Nucci M, Gloria AB, Silla L et al, Prospective surveillance study of invasive fungal infection in hemopoietic stem cell transplant recipients and in patients with acute myeloid leukemia. 51th ICAAC, Chicago (USA) 16-20 September 2011, M-1508
25. Pagano L, Caira M, Picardi M et al (2007) Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality-SEIFEM-C Report. Clin Infect Dis 44:1524-1525 (Pubitemid 46801604)
26. Lin SJ, Schranz J, Teutsch SM (2001) Aspergillosis casefatality rate: systematic review of the literature. Clin Infect Dis 32:358-366 (Pubitemid 32173620)